Driehaus Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-220,384
| Closed | -$18.4M | – | 400 |
|
|
2023
Q4 | $18.4M | Buy |
+220,384
| New | +$18.4M | 0.22% | 144 |
|
|
2023
Q2 | – | Sell |
-365,348
| Closed | -$12.9M | – | 407 |
|
|
2023
Q1 | $12.9M | Sell |
365,348
-1,009
| -0.3% | -$35.5K | 0.18% | 184 |
|
|
2022
Q4 | $16.8M | Sell |
366,357
-1,239,957
| -77% | -$56.8M | 0.25% | 136 |
|
|
2022
Q3 | $77.8M | Sell |
1,606,314
-41,340
| -3% | -$2M | 1.18% | 11 |
|
|
2022
Q2 | $64.7M | Sell |
1,647,654
-239,509
| -13% | -$9.41M | 1.05% | 12 |
|
|
2022
Q1 | $69.5M | Sell |
1,887,163
-439,949
| -19% | -$16.2M | 0.85% | 17 |
|
|
2021
Q4 | $106M | Sell |
2,327,112
-562,414
| -19% | -$25.6M | 1.08% | 15 |
|
|
2021
Q3 | $103M | Sell |
2,889,526
-210,131
| -7% | -$7.51M | 1.22% | 6 |
|
|
2021
Q2 | $61.3M | Sell |
3,099,657
-135,981
| -4% | -$2.69M | 0.81% | 21 |
|
|
2021
Q1 | $75.3M | Buy |
3,235,638
+9,071
| +0.3% | +$211K | 1.11% | 12 |
|
|
2020
Q4 | $67M | Buy |
3,226,567
+194,869
| +6% | +$4.05M | 1.08% | 12 |
|
|
2020
Q3 | $65.6M | Sell |
3,031,698
-77,674
| -2% | -$1.68M | 1.35% | 9 |
|
|
2020
Q2 | $73.3M | Buy |
3,109,372
+135,770
| +5% | +$3.2M | 1.78% | 3 |
|
|
2020
Q1 | $35.1M | Sell |
2,973,602
-65,654
| -2% | -$774K | 1.17% | 13 |
|
|
2019
Q4 | $32.2M | Buy |
3,039,256
+319,091
| +12% | +$3.39M | 0.86% | 19 |
|
|
2019
Q3 | $31M | Buy |
2,720,165
+532,551
| +24% | +$6.06M | 1.01% | 14 |
|
|
2019
Q2 | $24.6M | Buy |
+2,187,614
| New | +$24.6M | 0.77% | 29 |
|
|
2014
Q3 | – | Sell |
-205,019
| Closed | -$980K | – | 538 |
|
|
2014
Q2 | $980K | Sell |
205,019
-19,379
| -9% | -$92.6K | 0.03% | 440 |
|
|
2014
Q1 | $2.13M | Buy |
+224,398
| New | +$2.13M | 0.07% | 321 |
|